Penumbra (PEN) Deferred Taxes (2015 - 2026)
Penumbra's (PEN) quarterly Deferred Taxes came in at -$727000.0 in Q1 2026, up 63.61% year-on-year from -$444339.6 in Q1 2025, and down 104.83% on a QoQ basis from $15.1 million in Q4 2025.
Penumbra (PEN) Deferred Taxes (2015 - 2026) Analysis & Trends
Penumbra (PEN) has 12 years of Deferred Taxes data on file, last reported at -$727000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 63.61% year-over-year to -$727000.0 in Q1 2026; TTM through Mar 2026 was $22.3 million, a 218.57% increase from a year earlier, with the FY2025 full-year figure at $21.0 million, up 228.73% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$727000.0, down from $15.1 million in the prior quarter.
- Over the last five years, Deferred Taxes for PEN reached as high as $15.1 million in Q4 2025 and fell as low as -$24.2 million in Q2 2024.
- Historically, Deferred Taxes has averaged -$802058.8 across 5 years, with a median of -$727000.0 in 2026.
- Across the five-year window, Deferred Taxes tumbled 1517.3% in 2024 and surged 426.31% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at -$1.3 million in 2022, then tumbled by 1313.52% to -$19.0 million in 2023, then soared by 124.18% to $4.6 million in 2024, then jumped by 227.39% to $15.1 million in 2025, then sank by 104.83% to -$727000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$727000.0 in Q1 2026, $15.1 million in Q4 2025, and $14.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | -727,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -727,000.00 |
| Dec 31, 2025 | 15.06 Mn |
| Sep 30, 2025 | 14.72 Mn |
| Jun 30, 2025 | -6.75 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | -24.21 Mn |
| Mar 31, 2024 | 475,000.00 |
| Dec 31, 2023 | -19.03 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | -1.50 Mn |
| Mar 31, 2023 | -953,000.00 |
| Dec 31, 2022 | -1.35 Mn |
| Sep 30, 2022 | 5.55 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | -4.38 Mn |
| Dec 31, 2021 | -14.90 Mn |
| Sep 30, 2021 | -1.76 Mn |
| Jun 30, 2021 | 1.35 Mn |